Adcendo ApS
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors (NCT07362888) | Adcendo ApS | 2026-03-17 |
| First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma (NCT06797999) | Adcendo ApS | 2025-06-05 |
| ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours (NCT06597721) | Adcendo ApS | 2024-11-25 |
Track Adcendo ApS automatically
Every clearance here is in the API, with alerts when new ones post.